Meta-analysis of randomized trials finds NOAC reduces systemic embolic events risk in atrial fibrillation, indicating important clinical benefits.
This population-based simulation study evaluates semaglutide's cost-effectiveness for CVD prevention in US adults, indicating significant health benefits and budget impact.
Meta-analysis shows no sex-related differences in long-term therapy outcomes in coronary syndrome, indicating similar treatment efficacy.
Narrative review reveals cardiovascular risks of common non-oncologic drugs, highlighting clinical implications.
This statement identifies diagnostic and management challenges for premenopausal women with acute coronary syndrome, highlighting implications for care.
Randomized trial shows abelacimab reduces bleeding risk in older individuals with atrial fibrillation, suggesting a safer option.
This review explores computational modelling's role in assessing TAVI durability, guiding interventions for younger populations.
Demonstrates how brain leptin receptors promote heart protection via BAT-derived extracellular vesicles, suggesting new therapeutic strategies.
Structured narrative review explores extracellular vesicles' impact on cardiac amyloidosis, suggesting diagnostic and therapeutic potential.
Cross-sectional research estimates myocardial infarction frequency in young patients, suggesting significant risk factors.